TOLVAPTAN

TOLVAPTAN was reported 14926 times

TOLVAPTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RAPID CORRECTION OF HYPONATRAEMIA 204 0.8127
1 RENAL CYST RUPTURED 32 0.2370
2 URINE OSMOLARITY DECREASED 19 0.1557
3 POLYCYSTIC LIVER DISEASE 15 0.1415
4 RENAL CYST HAEMORRHAGE 29 0.1283
5 PULMONARY VEIN OCCLUSION 9 0.1111
6 RENAL CYST INFECTION 16 0.1006
7 LOW CARDIAC OUTPUT SYNDROME 30 0.0898
8 URINE OSMOLARITY INCREASED 12 0.0774
9 HYPERNATRAEMIA 367 0.0736
10 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 44 0.0664
11 INVESTIGATION NONCOMPLIANCE 7 0.0642
12 FLUID INTAKE RESTRICTION 7 0.0636
13 HEPATIC CYST INFECTION 6 0.0612
14 BLOOD SODIUM INCREASED 165 0.0611
15 THIRST 1026 0.0574
16 POLYURIA 464 0.0566
17 OSMOTIC DEMYELINATION SYNDROME 41 0.0556
18 POLYDIPSIA 216 0.0546
19 BILIRUBIN URINE PRESENT 6 0.0504
20 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 8 0.0460
21 PROCEDURAL FAILURE 8 0.0449
22 DEFECT CONDUCTION INTRAVENTRICULAR 14 0.0432
23 CYST RUPTURE 27 0.0398
24 CARDIAC FAILURE CHRONIC 159 0.0373
25 LIVER CARCINOMA RUPTURED 8 0.0317
26 CREATININE URINE DECREASED 5 0.0316
27 RENAL TRANSPLANT 114 0.0315
28 HAEMORRHAGIC CYST 12 0.0310
29 CARDIAC OUTPUT INCREASED 5 0.0292
30 IMMOBILISATION SYNDROME 6 0.0282
31 BLOOD SODIUM ABNORMAL 28 0.0263
32 GLOMERULAR FILTRATION RATE DECREASED 320 0.0260
33 NOCTURIA 295 0.0243
34 ASPARTATE AMINOTRANSFERASE DECREASED 12 0.0226
35 URAEMIC ENCEPHALOPATHY 7 0.0224
36 CONGESTIVE HEPATOPATHY 10 0.0223
37 PROTEIN-LOSING GASTROENTEROPATHY 11 0.0221
38 ALANINE AMINOTRANSFERASE DECREASED 16 0.0221
39 BLOOD SODIUM DECREASED 374 0.0198
40 BRAIN NATRIURETIC PEPTIDE INCREASED 60 0.0194
41 CARBON DIOXIDE DECREASED 22 0.0191
42 MARASMUS 29 0.0191
43 TRANSPLANT 45 0.0189
44 PULMONARY VENO-OCCLUSIVE DISEASE 13 0.0186
45 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 26 0.0185
46 RHYTHM IDIOVENTRICULAR 6 0.0185
47 HYPERURICAEMIA 75 0.0182
48 BLOOD CHLORIDE INCREASED 31 0.0179
49 BLOOD UREA INCREASED 296 0.0177
50 URINE OUTPUT INCREASED 46 0.0176
51 KIDNEY ENLARGEMENT 18 0.0165
52 BRONCHIAL CARCINOMA 13 0.0165
53 CONGENITAL CYSTIC KIDNEY DISEASE 13 0.0153
54 RIGHT VENTRICULAR FAILURE 107 0.0153
55 DIALYSIS 216 0.0152
56 BLOOD OSMOLARITY INCREASED 5 0.0152
57 UPPER RESPIRATORY TRACT INFLAMMATION 18 0.0150
58 PRERENAL FAILURE 21 0.0149
59 POLLAKIURIA 616 0.0148
60 HEPATIC ENCEPHALOPATHY 134 0.0143
61 OESOPHAGEAL VARICES HAEMORRHAGE 30 0.0138
62 CARDIAC AMYLOIDOSIS 15 0.0136
63 HEPATORENAL SYNDROME 23 0.0136
64 GLOMERULAR FILTRATION RATE INCREASED 11 0.0133
65 BLOOD ALKALINE PHOSPHATASE DECREASED 12 0.0126
66 JUGULAR VEIN DISTENSION 7 0.0123
67 CONCOMITANT DISEASE PROGRESSION 24 0.0123
68 CARDIORENAL SYNDROME 7 0.0122
69 COLONOSCOPY 25 0.0113
70 BLOOD OSMOLARITY DECREASED 7 0.0112
71 THIRST DECREASED 7 0.0111
72 RENAL ISCHAEMIA 6 0.0110
73 HYPERCHLORAEMIA 7 0.0109
74 PERITONEAL DIALYSIS 9 0.0109
75 CONCOMITANT DISEASE AGGRAVATED 66 0.0107
76 CARDIAC FAILURE ACUTE 71 0.0106
77 AORTIC VALVE STENOSIS 19 0.0106
78 BLOOD PHOSPHORUS ABNORMAL 5 0.0106
79 RENAL IMPAIRMENT 891 0.0106
80 HEPATIC CYST 36 0.0106
81 DRUG MONITORING PROCEDURE NOT PERFORMED 19 0.0106
82 HEPATIC CONGESTION 10 0.0106
83 ATRIAL TACHYCARDIA 22 0.0105
84 CARDIAC FAILURE 828 0.0103
85 BLOOD URIC ACID INCREASED 59 0.0102
86 DRUG TITRATION ERROR 26 0.0101
87 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 11 0.0099
88 GLOMERULAR FILTRATION RATE ABNORMAL 14 0.0099
89 HEPATIC FUNCTION ABNORMAL 357 0.0096
90 LIVER TRANSPLANT 34 0.0093
91 SMALL CELL LUNG CANCER 14 0.0093
92 HAEMORRHAGIC INFARCTION 5 0.0091
93 FLUID INTAKE REDUCED 45 0.0090
94 PULMONARY ARTERIAL HYPERTENSION 130 0.0090
95 URINE OUTPUT DECREASED 77 0.0088
96 CHYLOTHORAX 6 0.0083
97 ISCHAEMIC HEPATITIS 11 0.0080
98 GALLBLADDER POLYP 6 0.0076
99 INFECTED CYST 9 0.0075
100 BLOOD CREATININE INCREASED 478 0.0073
101 CYTOMEGALOVIRUS TEST POSITIVE 13 0.0073
102 INCORRECT DRUG ADMINISTRATION RATE 31 0.0073
103 MEDICAL PROCEDURE 12 0.0072
104 DACTYLITIS 7 0.0071
105 FLUID IMBALANCE 5 0.0071
106 PHYSICAL DECONDITIONING 18 0.0070
107 BLOOD CHLORIDE DECREASED 18 0.0070
108 PULMONARY CONGESTION 92 0.0070
109 INCORRECT DRUG ADMINISTRATION DURATION 196 0.0070
110 INABILITY TO AFFORD MEDICATION 69 0.0069
111 UNDERDOSE 499 0.0068
112 INCORRECT PRODUCT ADMINISTRATION DURATION 148 0.0068
113 CARDIAC OUTPUT DECREASED 6 0.0068
114 ANION GAP INCREASED 9 0.0067
115 NEPHROGENIC ANAEMIA 31 0.0067
116 CATHETER MANAGEMENT 6 0.0067
117 BLOOD POTASSIUM INCREASED 108 0.0066
118 DIABETES INSIPIDUS 16 0.0066
119 CHOLANGITIS ACUTE 5 0.0066
120 DISSEMINATED CRYPTOCOCCOSIS 5 0.0066
121 CEREBRAL ARTERY EMBOLISM 8 0.0066
122 CRITICAL ILLNESS 5 0.0064
123 HYPERCAPNIA 19 0.0063
124 METABOLIC ALKALOSIS 10 0.0062
125 RENAL PAIN 66 0.0062
126 PRESCRIBED UNDERDOSE 123 0.0062
127 HYPOCHLORAEMIA 7 0.0060
128 CARDIAC DYSFUNCTION 22 0.0059
129 BLOOD PARATHYROID HORMONE INCREASED 17 0.0058
130 LIVER INJURY 143 0.0058
131 HYPONATRAEMIA 316 0.0056
132 CARDIAC ABLATION 10 0.0056
133 ALTERED STATE OF CONSCIOUSNESS 120 0.0055
134 HYPERKALAEMIA 194 0.0055
135 LEFT VENTRICULAR FAILURE 19 0.0055
136 SINUS NODE DYSFUNCTION 10 0.0055
137 CARDIAC VENTRICULAR THROMBOSIS 7 0.0054
138 BLOOD UREA ABNORMAL 5 0.0053
139 METABOLIC SURGERY 6 0.0053
140 ALANINE AMINOTRANSFERASE INCREASED 324 0.0053
141 HYPOPROTEINAEMIA 10 0.0053
142 ASPARTATE AMINOTRANSFERASE INCREASED 280 0.0053
143 PRODUCT PRESCRIBING ISSUE 114 0.0052
144 INSURANCE ISSUE 80 0.0052
145 OCCULT BLOOD POSITIVE 10 0.0051
146 LIVER FUNCTION TEST INCREASED 109 0.0051
147 BILIARY TRACT DISORDER 7 0.0051
148 FLANK PAIN 47 0.0050
149 HYPERAMMONAEMIA 25 0.0050
150 HEPATOCELLULAR CARCINOMA 38 0.0050
151 CEREBRAL INFARCTION 122 0.0050
152 PSEUDOMEMBRANOUS COLITIS 11 0.0049
153 BLOOD CREATININE ABNORMAL 17 0.0049
154 DRUG DOSE TITRATION NOT PERFORMED 9 0.0049
155 PULMONARY ARTERIAL PRESSURE INCREASED 8 0.0049
156 GASTRIC POLYPS 11 0.0049
157 HEPATIC CIRRHOSIS 90 0.0048
158 ASCITES 139 0.0047
159 HEPATITIS FULMINANT 14 0.0047
160 NEPHRECTOMY 7 0.0047
161 ORTHOPNOEA 15 0.0047
162 PULMONARY HYPERTENSION 98 0.0047
163 PLATELET TRANSFUSION 6 0.0047
164 GASTROINTESTINAL OEDEMA 8 0.0045
165 AZOTAEMIA 18 0.0045
166 INTRACRANIAL ANEURYSM 18 0.0045
167 RENAL CYST 35 0.0044
168 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
169 HYPOALBUMINAEMIA 33 0.0042
170 HERNIA REPAIR 11 0.0042
171 PORTAL HYPERTENSION 13 0.0042
172 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 43 0.0042
173 HYPERPHOSPHATAEMIA 9 0.0042
174 BLOOD BILIRUBIN INCREASED 113 0.0042
175 CARDIAC DEATH 5 0.0041
176 BILIARY DILATATION 6 0.0041
177 VENTRICULAR HYPOKINESIA 13 0.0040
178 MICTURITION DISORDER 14 0.0040
179 BLOOD UREA DECREASED 5 0.0040
180 HYPOPITUITARISM 7 0.0040
181 HEPATIC FAILURE 121 0.0040
182 IRON DEFICIENCY ANAEMIA 37 0.0040
183 AORTIC VALVE INCOMPETENCE 17 0.0040
184 EMBOLIC STROKE 14 0.0040
185 ASPARTATE AMINOTRANSFERASE ABNORMAL 6 0.0039
186 GLUCOSE URINE PRESENT 5 0.0039
187 VENTRICULAR TACHYCARDIA 64 0.0039
188 ATRIAL THROMBOSIS 8 0.0039
189 TUMOUR HAEMORRHAGE 11 0.0039
190 CONDUCTION DISORDER 7 0.0038
191 INTENTIONAL DOSE OMISSION 107 0.0037
192 LIVER DISORDER 166 0.0037
193 BLOOD PRESSURE SYSTOLIC DECREASED 17 0.0037
194 TRANSFUSION 39 0.0037
195 PROTEIN TOTAL DECREASED 14 0.0037
196 GAMMA-GLUTAMYLTRANSFERASE INCREASED 82 0.0037
197 BLOOD BICARBONATE DECREASED 7 0.0037
198 CARBON DIOXIDE INCREASED 5 0.0037
199 BLOOD PHOSPHORUS INCREASED 10 0.0037
200 DEHYDRATION 488 0.0037
201 MEAN CELL HAEMOGLOBIN INCREASED 6 0.0036
202 MITRAL VALVE INCOMPETENCE 41 0.0036
203 PROTEIN URINE PRESENT 18 0.0036
204 VENTRICULAR FIBRILLATION 40 0.0036
205 HYPERPARATHYROIDISM SECONDARY 9 0.0036
206 HYPOVOLAEMIA 21 0.0036
207 PNEUMONIA ASPIRATION 89 0.0036
208 OLIGURIA 22 0.0035
209 ENTERITIS INFECTIOUS 6 0.0035
210 DISSEMINATED INTRAVASCULAR COAGULATION 49 0.0035
211 PYELONEPHRITIS 30 0.0035
212 DYSPNOEA AT REST 10 0.0034
213 RENAL HAEMORRHAGE 7 0.0034
214 LUNG OPACITY 9 0.0034
215 AORTIC DISSECTION 14 0.0034
216 BLOOD ALKALINE PHOSPHATASE INCREASED 83 0.0033
217 AMMONIA INCREASED 17 0.0033
218 NEUROGENIC BLADDER 7 0.0033
219 GENERALISED OEDEMA 41 0.0033
220 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
221 AMYLASE INCREASED 12 0.0032
222 CATHETER SITE INFECTION 12 0.0032
223 GASTROINTESTINAL PERFORATION 13 0.0031
224 END STAGE RENAL DISEASE 57 0.0031
225 EOSINOPHIL COUNT INCREASED 26 0.0031
226 LARGE INTESTINAL HAEMORRHAGE 7 0.0031
227 CYSTITIS INTERSTITIAL 5 0.0031
228 PORTAL VEIN THROMBOSIS 10 0.0031
229 BLOOD PRESSURE DECREASED 205 0.0031
230 MICTURITION URGENCY 35 0.0031
231 BRADYARRHYTHMIA 5 0.0030
232 BLOOD ALBUMIN DECREASED 24 0.0030
233 ANURIA 26 0.0030
234 TRANSAMINASES INCREASED 67 0.0030
235 CARDIOMEGALY 37 0.0030
236 BLOOD POTASSIUM ABNORMAL 8 0.0030
237 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
238 SMALL INTESTINAL HAEMORRHAGE 6 0.0030
239 CONTRAINDICATED PRODUCT PRESCRIBED 5 0.0030
240 HEPATOTOXICITY 66 0.0030
241 DRY MOUTH 240 0.0030
242 PLEURAL EFFUSION 179 0.0029
243 URINARY HESITATION 7 0.0029
244 ENDOCARDITIS 15 0.0029
245 AMYLOIDOSIS 5 0.0029
246 TRICUSPID VALVE INCOMPETENCE 23 0.0029
247 FAECES SOFT 21 0.0029
248 OEDEMA 156 0.0029
249 BLOOD CREATININE DECREASED 9 0.0029
250 ALANINE AMINOTRANSFERASE ABNORMAL 6 0.0028
251 PROTHROMBIN TIME PROLONGED 17 0.0028
252 HAEMORRHAGIC DIATHESIS 10 0.0028
253 LUNG CANCER METASTATIC 8 0.0028
254 HAEMOTHORAX 8 0.0028
255 ATRIAL FLUTTER 22 0.0028
256 HYPOKALAEMIA 127 0.0027
257 CANCER PAIN 7 0.0027
258 ESSENTIAL HYPERTENSION 5 0.0027
259 MEAN CELL VOLUME INCREASED 7 0.0027
260 BLOOD CREATINE INCREASED 12 0.0027
261 HIGH DENSITY LIPOPROTEIN DECREASED 9 0.0027
262 FAECES PALE 6 0.0027
263 BLOOD POTASSIUM DECREASED 81 0.0027
264 ILEUS PARALYTIC 12 0.0027
265 URINE ANALYSIS ABNORMAL 8 0.0027
266 THYROIDITIS 8 0.0027
267 TONGUE ULCERATION 9 0.0027
268 NO ADVERSE EVENT 482 0.0027
269 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 537 0.0026
270 PRODUCT DOSE OMISSION ISSUE 779 0.0026
271 HAEMATOCRIT INCREASED 6 0.0026
272 HAEMOGLOBIN INCREASED 12 0.0026
273 HEPATITIS ACUTE 17 0.0026
274 INFUSION SITE ERYTHEMA 22 0.0026
275 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 461 0.0026
276 SUBDURAL HAEMATOMA 36 0.0025
277 THERAPY CESSATION 129 0.0025
278 URINE FLOW DECREASED 6 0.0025
279 PRODUCT DOSE OMISSION IN ERROR 71 0.0025
280 ENDOTRACHEAL INTUBATION 7 0.0025
281 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 176 0.0025
282 HAEMATOCRIT DECREASED 49 0.0025
283 NEUTROPHIL COUNT INCREASED 25 0.0024
284 INJECTION SITE INFECTION 8 0.0024
285 VASCULAR DEVICE INFECTION 11 0.0024
286 ORGANISING PNEUMONIA 12 0.0024
287 URINE ABNORMALITY 11 0.0024
288 CHOLANGITIS 15 0.0024
289 TACHYARRHYTHMIA 6 0.0024
290 INFUSION SITE SWELLING 15 0.0024
291 RENAL DISORDER 111 0.0024
292 INTESTINAL ISCHAEMIA 13 0.0024
293 HEPATIC ENZYME INCREASED 159 0.0023
294 CARDIAC OPERATION 20 0.0023
295 VARICES OESOPHAGEAL 7 0.0023
296 CARDIAC TAMPONADE 11 0.0023
297 HEPATITIS TOXIC 6 0.0023
298 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
299 PRODUCT USE ISSUE 430 0.0023
300 PNEUMONIA BACTERIAL 21 0.0023
301 DIABETIC NEPHROPATHY 5 0.0023
302 SUDDEN DEATH 24 0.0023
303 CARDIAC FAILURE CONGESTIVE 182 0.0023
304 HAEMORRHAGE SUBCUTANEOUS 8 0.0023
305 ENTEROCOLITIS 13 0.0022
306 BACTERIAL TEST POSITIVE 5 0.0022
307 CIRCULATORY COLLAPSE 38 0.0022
308 HOSPICE CARE 22 0.0022
309 HYPERVOLAEMIA 11 0.0022
310 DIVERTICULUM INTESTINAL HAEMORRHAGIC 5 0.0022
311 SCLERODERMA 8 0.0022
312 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
313 NEPHROTIC SYNDROME 15 0.0022
314 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
315 SKIN EROSION 7 0.0022
316 LARGE INTESTINE POLYP 15 0.0022
317 ELECTROLYTE IMBALANCE 25 0.0021
318 DRUG ERUPTION 38 0.0021
319 LISTLESS 7 0.0021
320 SEPTIC SHOCK 92 0.0021
321 DUODENAL ULCER HAEMORRHAGE 6 0.0021
322 LYMPHOCYTE COUNT DECREASED 37 0.0021
323 KIDNEY INFECTION 41 0.0021
324 DEVICE RELATED INFECTION 32 0.0021
325 DIZZINESS POSTURAL 20 0.0021
326 GOUT 37 0.0021
327 PLATELET COUNT DECREASED 219 0.0021
328 SUDDEN CARDIAC DEATH 7 0.0021
329 COMPRESSION FRACTURE 11 0.0021
330 PRODUCT USE IN UNAPPROVED INDICATION 502 0.0020
331 VENTRICULAR EXTRASYSTOLES 21 0.0020
332 COLON CANCER 30 0.0020
333 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
334 RED BLOOD CELL COUNT DECREASED 57 0.0020
335 INTERSTITIAL LUNG DISEASE 96 0.0020
336 DRUG-INDUCED LIVER INJURY 62 0.0020
337 FIBRIN D DIMER INCREASED 7 0.0020
338 DISEASE COMPLICATION 9 0.0020
339 ACIDOSIS 15 0.0020
340 PRODUCT DISTRIBUTION ISSUE 18 0.0019
341 RENAL FUNCTION TEST ABNORMAL 9 0.0019
342 SPINAL COMPRESSION FRACTURE 16 0.0019
343 LIPOMA 5 0.0019
344 MONOCYTE COUNT INCREASED 7 0.0019
345 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
346 CONGESTIVE CARDIOMYOPATHY 8 0.0019
347 ACUTE KIDNEY INJURY 293 0.0019
348 HAEMATURIA 65 0.0019
349 LABORATORY TEST ABNORMAL 56 0.0019
350 FACE OEDEMA 32 0.0019
351 RALES 11 0.0019
352 SUPRAVENTRICULAR TACHYCARDIA 18 0.0019
353 BLOOD CREATINE PHOSPHOKINASE INCREASED 54 0.0019
354 SHOULDER OPERATION 8 0.0019
355 BLOOD CALCIUM DECREASED 21 0.0019
356 HYPOXIA 65 0.0018
357 WRONG TECHNIQUE IN DRUG USAGE PROCESS 66 0.0018
358 ADRENAL INSUFFICIENCY 22 0.0018
359 HEPATIC ENZYME ABNORMAL 9 0.0018
360 ANAL HAEMORRHAGE 5 0.0018
361 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 6 0.0018
362 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
363 PNEUMONIA FUNGAL 7 0.0018
364 BACTERAEMIA 21 0.0018
365 THERAPY INTERRUPTED 126 0.0018
366 OESOPHAGEAL CANDIDIASIS 7 0.0018
367 ABDOMINAL HERNIA 8 0.0018
368 IMMUNE THROMBOCYTOPENIA 8 0.0017
369 EYE OPERATION 8 0.0017
370 HYSTERECTOMY 15 0.0017
371 ADENOVIRUS INFECTION 5 0.0017
372 SHOCK HAEMORRHAGIC 14 0.0017
373 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7 0.0017
374 UMBILICAL HERNIA 8 0.0017
375 HAEMOGLOBIN ABNORMAL 11 0.0017
376 SHOCK 39 0.0017
377 ILEUS 21 0.0017
378 CONJUNCTIVAL HYPERAEMIA 6 0.0017
379 DEPRESSED LEVEL OF CONSCIOUSNESS 66 0.0017
380 HAEMODIALYSIS 14 0.0017
381 LUNG ADENOCARCINOMA 5 0.0017
382 BUNDLE BRANCH BLOCK LEFT 7 0.0016
383 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
384 DYSPNOEA EXERTIONAL 62 0.0016
385 PERICARDIAL EFFUSION 38 0.0016
386 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
387 VENTRICULAR ARRHYTHMIA 6 0.0016
388 DYSCHEZIA 5 0.0016
389 MELAENA 36 0.0016
390 FLUID RETENTION 82 0.0016
391 HEPATIC STEATOSIS 30 0.0016
392 SURGERY 94 0.0016
393 HYDRONEPHROSIS 12 0.0016
394 DIVERTICULUM INTESTINAL 7 0.0016
395 URINARY RETENTION 53 0.0016
396 CHOLECYSTITIS ACUTE 9 0.0016
397 LIVER FUNCTION TEST ABNORMAL 46 0.0016
398 BLOOD URINE PRESENT 30 0.0016
399 HAEMOPTYSIS 44 0.0016
400 GASTROENTERITIS 23 0.0016
401 TONGUE OEDEMA 6 0.0016
402 SLEEP DISORDER 111 0.0016
403 BILE DUCT STONE 5 0.0016
404 SUBARACHNOID HAEMORRHAGE 16 0.0016
405 HAEMOGLOBIN DECREASED 161 0.0016
406 HAEMOLYTIC ANAEMIA 14 0.0016
407 FEMORAL NECK FRACTURE 8 0.0016
408 GASTROENTERITIS VIRAL 28 0.0015
409 NEPHROPATHY TOXIC 17 0.0015
410 DECREASED APPETITE 351 0.0015
411 CHOLECYSTITIS 18 0.0015
412 TREATMENT NONCOMPLIANCE 82 0.0015
413 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
414 RESPIRATORY FAILURE 108 0.0015
415 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
416 SEPSIS 165 0.0015
417 CHROMATURIA 33 0.0015
418 PANCYTOPENIA 81 0.0014
419 CERVICAL VERTEBRAL FRACTURE 5 0.0014
420 HYPERBILIRUBINAEMIA 15 0.0014
421 RENAL FAILURE 192 0.0014
422 GASTRIC ULCER HAEMORRHAGE 8 0.0014
423 DIVERTICULITIS 40 0.0014
424 OROPHARYNGEAL DISCOMFORT 13 0.0014
425 LIPASE INCREASED 11 0.0014
426 HAEMORRHOIDAL HAEMORRHAGE 7 0.0014
427 PULMONARY OEDEMA 64 0.0014
428 ATRIAL FIBRILLATION 139 0.0014
429 HEPATOMEGALY 14 0.0014
430 STAPHYLOCOCCAL SEPSIS 7 0.0014
431 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
432 FOOT OPERATION 7 0.0014
433 OEDEMA PERIPHERAL 172 0.0014
434 ABDOMINAL TENDERNESS 7 0.0014
435 WHITE BLOOD CELL COUNT INCREASED 54 0.0014
436 ANEURYSM 7 0.0014
437 CHOLECYSTECTOMY 16 0.0014
438 INTERNAL HAEMORRHAGE 16 0.0014
439 ARTERIAL OCCLUSIVE DISEASE 11 0.0014
440 ACUTE HEPATIC FAILURE 19 0.0014
441 HEPATIC LESION 6 0.0014
442 PNEUMOTHORAX 22 0.0014
443 CORONARY ARTERIAL STENT INSERTION 7 0.0014
444 ANAEMIA 263 0.0014
445 DYSLIPIDAEMIA 7 0.0014
446 ORTHOSTATIC HYPOTENSION 24 0.0014
447 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
448 BLOOD CALCIUM INCREASED 12 0.0014
449 HYPERTRIGLYCERIDAEMIA 8 0.0014
450 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
451 ADVERSE EVENT 124 0.0013
452 FAECES DISCOLOURED 29 0.0013
453 PRODUCT SUBSTITUTION ISSUE 77 0.0013
454 FEEDING DISORDER 27 0.0013
455 RENAL TUBULAR NECROSIS 13 0.0013
456 CARDIOGENIC SHOCK 19 0.0013
457 THERAPY CHANGE 13 0.0013
458 CHEMOTHERAPY 5 0.0013
459 HAEMODYNAMIC INSTABILITY 10 0.0013
460 CHRONIC KIDNEY DISEASE 99 0.0013
461 DELIRIUM 45 0.0013
462 ABDOMINAL DISTENSION 135 0.0013
463 NEPHROPATHY 12 0.0013
464 FAECES HARD 5 0.0013
465 MUSCLE RUPTURE 5 0.0013
466 HYPOTHYROIDISM 41 0.0013
467 PULMONARY HAEMORRHAGE 10 0.0013
468 DUODENAL ULCER 9 0.0013
469 SYNCOPE 127 0.0013
470 CARDIO-RESPIRATORY ARREST 53 0.0013
471 BRADYCARDIA 67 0.0013
472 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0013
473 HOSPITALISATION 193 0.0013
474 HUMERUS FRACTURE 6 0.0012
475 ATELECTASIS 12 0.0012
476 HYPOTENSION 249 0.0012
477 PNEUMONIA 399 0.0012
478 THROMBOTIC MICROANGIOPATHY 12 0.0012
479 DYSURIA 45 0.0012
480 GASTROINTESTINAL HAEMORRHAGE 102 0.0012
481 BREATH SOUNDS ABNORMAL 6 0.0012
482 DEATH 1043 0.0012
483 STRESS CARDIOMYOPATHY 7 0.0012
484 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
485 PEMPHIGOID 9 0.0012
486 TOXIC SKIN ERUPTION 12 0.0012
487 ILLNESS 122 0.0012
488 HAEMATEMESIS 30 0.0012
489 PRODUCT PRESCRIBING ERROR 28 0.0012
490 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6 0.0012
491 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
492 LYMPHOMA 18 0.0012
493 INFUSION SITE PAIN 15 0.0012
494 CARDIAC ARREST 96 0.0012
495 JAUNDICE 31 0.0012
496 HYPERTRANSAMINASAEMIA 8 0.0011
497 FOOD CRAVING 6 0.0011
498 BLOOD TEST ABNORMAL 16 0.0011
499 SERUM FERRITIN INCREASED 6 0.0011
500 HAEMORRHAGIC ANAEMIA 5 0.0011
501 NEPHROLITHIASIS 52 0.0011
502 CATHETERISATION CARDIAC 5 0.0011
503 C-REACTIVE PROTEIN INCREASED 41 0.0011
504 ARRHYTHMIA 53 0.0011
505 HIP SURGERY 6 0.0011
506 URINARY TRACT INFECTION 189 0.0011
507 CLOSTRIDIUM DIFFICILE INFECTION 24 0.0011
508 HYPOPHAGIA 28 0.0011
509 LUMBAR VERTEBRAL FRACTURE 5 0.0011
510 PERITONITIS BACTERIAL 11 0.0011
511 ACUTE CORONARY SYNDROME 9 0.0011
512 OXYGEN SATURATION DECREASED 61 0.0011
513 LOCALISED OEDEMA 5 0.0011
514 MIDDLE INSOMNIA 20 0.0011
515 ACUTE PULMONARY OEDEMA 6 0.0011
516 HYPOCALCAEMIA 20 0.0011
517 APPETITE DISORDER 7 0.0011
518 TROPONIN INCREASED 8 0.0011
519 ACUTE MYOCARDIAL INFARCTION 31 0.0011
520 CARDIAC VALVE DISEASE 6 0.0010
521 BLOOD MAGNESIUM DECREASED 9 0.0010
522 LIMB OPERATION 5 0.0010
523 MULTI-ORGAN FAILURE 18 0.0010
524 ACUTE RESPIRATORY FAILURE 20 0.0010
525 COLITIS ISCHAEMIC 7 0.0010
526 METASTASES TO LYMPH NODES 7 0.0010
527 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
528 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
529 EJECTION FRACTION DECREASED 16 0.0010
530 BRAIN FOG 16 0.0010
531 DECREASED ACTIVITY 11 0.0010
532 OFF LABEL USE 891 0.0010
533 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
534 LYMPHOEDEMA 7 0.0010
535 BLOOD IRON DECREASED 12 0.0010
536 PRODUCT DOSE OMISSION 66 0.0010
537 LARGE INTESTINE PERFORATION 7 0.0010
538 ASPIRATION 11 0.0010
539 FRACTURE 19 0.0010
540 LUNG NEOPLASM MALIGNANT 41 0.0010
541 HEPATITIS C 12 0.0010
542 MALNUTRITION 11 0.0010
543 NEUTROPHIL COUNT DECREASED 40 0.0010
544 MYELODYSPLASTIC SYNDROME 14 0.0010
545 HYPERTHYROIDISM 14 0.0010
546 ERYTHEMA MULTIFORME 9 0.0010
547 DERMATITIS CONTACT 11 0.0010
548 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
549 CEREBRAL HAEMORRHAGE 34 0.0009
550 PROTEINURIA 18 0.0009
551 SPLENOMEGALY 11 0.0009
552 FOOD POISONING 5 0.0009
553 HYPERGLYCAEMIA 34 0.0009
554 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
555 CARDIAC FLUTTER 6 0.0009
556 ANGIOEDEMA 41 0.0009
557 HIATUS HERNIA 12 0.0009
558 INJECTION SITE INDURATION 12 0.0009
559 CARDIAC MURMUR 8 0.0009
560 OESOPHAGITIS 10 0.0009
561 AGRANULOCYTOSIS 17 0.0009
562 CORONAVIRUS INFECTION 6 0.0009
563 HAEMOLYSIS 7 0.0009
564 ATRIOVENTRICULAR BLOCK 7 0.0009
565 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
566 PURPURA 8 0.0009
567 CONSTIPATION 197 0.0009
568 BRAIN INJURY 9 0.0009
569 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
570 FLUID OVERLOAD 13 0.0009
571 EATING DISORDER 19 0.0009
572 DRUG INTERACTION 140 0.0009
573 LIP DRY 8 0.0009
574 PERIPHERAL COLDNESS 12 0.0009
575 NEOPLASM MALIGNANT 58 0.0009
576 EXERCISE TOLERANCE DECREASED 5 0.0009
577 HYPOGLYCAEMIA 42 0.0009
578 AUTOIMMUNE HEPATITIS 6 0.0009
579 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
580 CELLULITIS 43 0.0009
581 ARTERIOSCLEROSIS 8 0.0008
582 CYTOKINE RELEASE SYNDROME 17 0.0008
583 CATARACT OPERATION 5 0.0008
584 HEMIPLEGIA 7 0.0008
585 PRODUCT SUPPLY ISSUE 6 0.0008
586 CARDIAC PACEMAKER INSERTION 5 0.0008
587 GENERAL PHYSICAL HEALTH DETERIORATION 97 0.0008
588 TASTE DISORDER 17 0.0008
589 DRUG PRESCRIBING ERROR 16 0.0008
590 CONTRAINDICATED PRODUCT ADMINISTERED 25 0.0008
591 HAEMORRHOIDS 16 0.0008
592 PYREXIA 283 0.0008
593 CYSTITIS 26 0.0008
594 RHABDOMYOLYSIS 34 0.0008
595 WEIGHT INCREASED 182 0.0008
596 SPINAL OPERATION 10 0.0008
597 RESPIRATORY DISORDER 24 0.0008
598 INTESTINAL PERFORATION 9 0.0008
599 CONDITION AGGRAVATED 241 0.0008
600 BRAIN OEDEMA 10 0.0008
601 GASTRIC CANCER 20 0.0008
602 DRY THROAT 8 0.0008
603 DISEASE PROGRESSION 93 0.0008
604 DRUG LEVEL INCREASED 13 0.0008
605 HEPATITIS 20 0.0008
606 ANAL INCONTINENCE 7 0.0008
607 PAIN IN JAW 22 0.0008
608 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
609 TENDERNESS 8 0.0008
610 LOSS OF CONSCIOUSNESS 98 0.0008
611 TORSADE DE POINTES 6 0.0008
612 STEVENS-JOHNSON SYNDROME 17 0.0008
613 BRAIN NEOPLASM 7 0.0008
614 UROSEPSIS 7 0.0008
615 INCONTINENCE 8 0.0008
616 MENTAL STATUS CHANGES 21 0.0008
617 HAEMATOCHEZIA 41 0.0007
618 URINARY INCONTINENCE 22 0.0007
619 METASTASES TO LIVER 13 0.0007
620 PULMONARY MASS 11 0.0007
621 HYPERCALCAEMIA 9 0.0007
622 GALLBLADDER DISORDER 13 0.0007
623 VIRAL INFECTION 24 0.0007
624 WHITE BLOOD CELL COUNT DECREASED 78 0.0007
625 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
626 DYSPHAGIA 68 0.0007
627 MUSCULOSKELETAL CHEST PAIN 11 0.0007
628 MUSCLE ATROPHY 9 0.0007
629 DIZZINESS 354 0.0007
630 INFLUENZA 79 0.0007
631 HEPATIC CANCER 17 0.0007
632 RENAL FAILURE ACUTE 30 0.0007
633 WEIGHT DECREASED 197 0.0007
634 BLADDER DISORDER 7 0.0007
635 DIVERTICULUM 5 0.0007
636 MYOCARDIAL ISCHAEMIA 8 0.0007
637 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
638 BACTERIAL INFECTION 13 0.0007
639 GRAFT VERSUS HOST DISEASE 5 0.0007
640 EPISTAXIS 52 0.0007
641 MALAISE 304 0.0007
642 ENCEPHALOPATHY 17 0.0007
643 PLATELET COUNT INCREASED 9 0.0007
644 RESPIRATORY ARREST 19 0.0007
645 HYPOKINESIA 10 0.0007
646 METABOLIC ACIDOSIS 22 0.0007
647 POST PROCEDURAL HAEMORRHAGE 8 0.0007
648 INTENTIONAL UNDERDOSE 5 0.0007
649 GASTRITIS 18 0.0007
650 GROIN PAIN 6 0.0007
651 DRY SKIN 91 0.0007
652 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
653 CARDIOMYOPATHY 10 0.0007
654 HERNIA 13 0.0007
655 KNEE ARTHROPLASTY 14 0.0007
656 INFECTION 96 0.0007
657 ANGINA PECTORIS 19 0.0007
658 ABDOMINAL PAIN 154 0.0007
659 PRODUCT AVAILABILITY ISSUE 15 0.0007
660 PULMONARY THROMBOSIS 7 0.0006
661 CHOLELITHIASIS 21 0.0006
662 DYSPEPSIA 63 0.0006
663 INJECTION SITE DISCOLOURATION 8 0.0006
664 HYPERTENSION 135 0.0006
665 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
666 GASTROOESOPHAGEAL REFLUX DISEASE 51 0.0006
667 NEOPLASM PROGRESSION 22 0.0006
668 RIB FRACTURE 13 0.0006
669 GASTRIC ULCER 12 0.0006
670 CARDIAC DISORDER 59 0.0006
671 EOSINOPHILIA 11 0.0006
672 HEPATIC CYTOLYSIS 8 0.0006
673 PANCREATITIS ACUTE 14 0.0006
674 DIARRHOEA 399 0.0006
675 PRESYNCOPE 15 0.0006
676 PALPITATIONS 72 0.0006
677 FEMUR FRACTURE 19 0.0006
678 DYSPNOEA 347 0.0006
679 DRUG INTOLERANCE 59 0.0006
680 MYOCARDITIS 7 0.0006
681 KNEE OPERATION 6 0.0006
682 ILL-DEFINED DISORDER 37 0.0006
683 DEMENTIA 17 0.0006
684 BLOOD PRESSURE INCREASED 93 0.0006
685 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
686 STAPHYLOCOCCAL INFECTION 20 0.0006
687 SEIZURE 70 0.0006
688 BLOOD GLUCOSE INCREASED 114 0.0006
689 MENSTRUAL DISORDER 5 0.0006
690 BLOOD PRESSURE ABNORMAL 12 0.0006
691 EYELID OEDEMA 7 0.0006
692 VOMITING 283 0.0006
693 HEAD INJURY 19 0.0006
694 ECONOMIC PROBLEM 9 0.0006
695 TACHYPNOEA 8 0.0006
696 ERECTILE DYSFUNCTION 15 0.0006
697 INTESTINAL OBSTRUCTION 22 0.0006
698 DISORIENTATION 23 0.0006
699 FOOT FRACTURE 11 0.0006
700 MUSCLE STRAIN 5 0.0006
701 FALL 192 0.0006
702 RESPIRATORY TRACT INFECTION 15 0.0006
703 FEELING COLD 16 0.0006
704 NO THERAPEUTIC RESPONSE 7 0.0006
705 LOWER LIMB FRACTURE 11 0.0006
706 NAUSEA 452 0.0006
707 INTENTIONAL PRODUCT USE ISSUE 50 0.0006
708 PLASMA CELL MYELOMA 22 0.0006
709 IMPAIRED QUALITY OF LIFE 8 0.0006
710 FATIGUE 431 0.0006
711 ABDOMINAL PAIN UPPER 113 0.0005
712 GASTROINTESTINAL PAIN 6 0.0005
713 CONFUSIONAL STATE 88 0.0005
714 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
715 BLOOD GLUCOSE DECREASED 26 0.0005
716 HYPERTENSIVE CRISIS 6 0.0005
717 NASOPHARYNGITIS 99 0.0005
718 PERICARDITIS 9 0.0005
719 INCORRECT DOSE ADMINISTERED 122 0.0005
720 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
721 DYSARTHRIA 20 0.0005
722 REBOUND EFFECT 6 0.0005
723 LEUKAEMIA 5 0.0005
724 DERMATITIS 11 0.0005
725 EPILEPSY 16 0.0005
726 HIP ARTHROPLASTY 8 0.0005
727 MYOCARDIAL INFARCTION 91 0.0005
728 LETHARGY 30 0.0005
729 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
730 BACK PAIN 120 0.0005
731 INSOMNIA 137 0.0005
732 IMPAIRED GASTRIC EMPTYING 7 0.0005
733 HEART RATE DECREASED 18 0.0005
734 CHOKING 10 0.0005
735 POOR QUALITY SLEEP 11 0.0005
736 DEPRESSED MOOD 27 0.0005
737 ASTHENIA 192 0.0005
738 LIGAMENT SPRAIN 5 0.0005
739 HYPOMAGNESAEMIA 7 0.0005
740 HEADACHE 315 0.0005
741 PRURITUS 190 0.0005
742 HYPOTHERMIA 5 0.0005
743 MUSCLE SPASMS 90 0.0005
744 PERIPHERAL SWELLING 75 0.0005
745 PERITONITIS 10 0.0005
746 CYTOMEGALOVIRUS INFECTION 8 0.0005
747 COAGULOPATHY 8 0.0005
748 COVID-19 84 0.0005
749 MALIGNANT NEOPLASM PROGRESSION 49 0.0005
750 FOLLICULITIS 5 0.0005
751 TACHYCARDIA 42 0.0005
752 MYELOSUPPRESSION 17 0.0005
753 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
754 SWELLING 44 0.0005
755 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
756 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
757 PRESCRIBED OVERDOSE 9 0.0005
758 HAEMATOMA 12 0.0005
759 SKIN FISSURES 9 0.0005
760 DIABETES MELLITUS 35 0.0005
761 BLOOD PRESSURE FLUCTUATION 11 0.0005
762 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
763 COLD SWEAT 8 0.0005
764 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
765 EYE HAEMORRHAGE 6 0.0004
766 PRODUCT ADMINISTRATION ERROR 9 0.0004
767 OSTEOMYELITIS 8 0.0004
768 HAEMORRHAGE 46 0.0004
769 PANCREATITIS 23 0.0004
770 THROMBOSIS 35 0.0004
771 ABDOMINAL PAIN LOWER 11 0.0004
772 GASTRIC HAEMORRHAGE 5 0.0004
773 CHEST PAIN 80 0.0004
774 ABDOMINAL DISCOMFORT 72 0.0004
775 DRUG RESISTANCE 11 0.0004
776 MOUTH ULCERATION 9 0.0004
777 ANAPHYLACTIC SHOCK 11 0.0004
778 SEASONAL ALLERGY 6 0.0004
779 COVID-19 PNEUMONIA 5 0.0004
780 IMPAIRED WORK ABILITY 9 0.0004
781 DEAFNESS 11 0.0004
782 PARALYSIS 6 0.0004
783 HYPERLIPIDAEMIA 5 0.0004
784 PULMONARY FIBROSIS 8 0.0004
785 CHOLESTASIS 8 0.0004
786 DEEP VEIN THROMBOSIS 27 0.0004
787 GLAUCOMA 8 0.0004
788 CANDIDA INFECTION 7 0.0004
789 RESTLESSNESS 15 0.0004
790 MUSCULOSKELETAL DISCOMFORT 7 0.0004
791 COUGH 114 0.0004
792 ROAD TRAFFIC ACCIDENT 17 0.0004
793 CONTUSION 39 0.0004
794 LIMB INJURY 11 0.0004
795 RASH MACULO-PAPULAR 9 0.0004
796 UPPER LIMB FRACTURE 8 0.0004
797 FEELING ABNORMAL 96 0.0004
798 COMA 19 0.0004
799 CORONARY ARTERY DISEASE 12 0.0004
800 MUSCULAR WEAKNESS 45 0.0004
801 CEREBROVASCULAR ACCIDENT 67 0.0004
802 VERTIGO 24 0.0004
803 BONE MARROW FAILURE 8 0.0004
804 GASTROINTESTINAL DISORDER 35 0.0004
805 MENTAL DISORDER 17 0.0004
806 SKIN ULCER 10 0.0004
807 CATARACT 23 0.0004
808 DRUG EFFECT INCOMPLETE 14 0.0004
809 HERPES ZOSTER 22 0.0004
810 PANCREATIC CARCINOMA 11 0.0004
811 SOMNOLENCE 76 0.0004
812 SCIATICA 6 0.0004
813 DRUG DOSE OMISSION 61 0.0004
814 ADVERSE DRUG REACTION 33 0.0004
815 LUNG DISORDER 18 0.0004
816 LYMPHADENOPATHY 13 0.0004
817 METASTASES TO BONE 6 0.0004
818 BRONCHITIS 27 0.0004
819 FUNGAL INFECTION 12 0.0004
820 APHONIA 5 0.0004
821 THROMBOCYTOPENIA 40 0.0004
822 PRODUCTIVE COUGH 17 0.0004
823 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
824 RASH GENERALISED 9 0.0003
825 FEBRILE NEUTROPENIA 23 0.0003
826 BLOOD CHOLESTEROL INCREASED 16 0.0003
827 HEART RATE INCREASED 34 0.0003
828 RHINORRHOEA 22 0.0003
829 IMMUNODEFICIENCY 5 0.0003
830 MIGRAINE 32 0.0003
831 JOINT INJURY 7 0.0003
832 DRUG ADMINISTRATION ERROR 10 0.0003
833 ABORTION SPONTANEOUS 13 0.0003
834 ACUTE MYELOID LEUKAEMIA 5 0.0003
835 CYANOSIS 5 0.0003
836 CONVULSION 18 0.0003
837 SLEEP APNOEA SYNDROME 6 0.0003
838 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
839 INCREASED APPETITE 6 0.0003
840 POST PROCEDURAL COMPLICATION 6 0.0003
841 INFLAMMATION 16 0.0003
842 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
843 SPEECH DISORDER 16 0.0003
844 PULMONARY EMBOLISM 29 0.0003
845 DEPRESSION 69 0.0003
846 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
847 SINUSITIS 31 0.0003
848 DRY EYE 15 0.0003
849 FULL BLOOD COUNT DECREASED 6 0.0003
850 PRODUCT PHYSICAL ISSUE 6 0.0003
851 PAIN OF SKIN 8 0.0003
852 THERAPEUTIC RESPONSE DECREASED 18 0.0003
853 STOMATITIS 18 0.0003
854 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
855 DYSGEUSIA 22 0.0003
856 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
857 PNEUMONITIS 8 0.0003
858 CHEST DISCOMFORT 30 0.0003
859 HOT FLUSH 22 0.0003
860 BALANCE DISORDER 25 0.0003
861 MENTAL IMPAIRMENT 7 0.0003
862 WHEEZING 17 0.0003
863 MUSCULOSKELETAL PAIN 15 0.0003
864 RASH MACULAR 10 0.0003
865 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
866 SKIN DISCOLOURATION 13 0.0003
867 HEAD DISCOMFORT 5 0.0003
868 ACCIDENTAL OVERDOSE 10 0.0003
869 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
870 EXTRA DOSE ADMINISTERED 11 0.0003
871 SKIN DISORDER 9 0.0003
872 OSTEOPOROSIS 11 0.0003
873 HEART RATE IRREGULAR 6 0.0003
874 APHASIA 8 0.0003
875 FLATULENCE 15 0.0003
876 RASH 115 0.0003
877 DISCOMFORT 16 0.0003
878 MENSTRUATION IRREGULAR 7 0.0003
879 TINNITUS 12 0.0003
880 OROPHARYNGEAL PAIN 24 0.0003
881 GYNAECOMASTIA 8 0.0003
882 JOINT SWELLING 31 0.0003
883 NERVOUS SYSTEM DISORDER 8 0.0003
884 HYPOACUSIS 11 0.0003
885 NASAL CONGESTION 15 0.0003
886 MEDICATION ERROR 14 0.0003
887 ECZEMA 13 0.0002
888 NIGHT SWEATS 8 0.0002
889 MEMORY IMPAIRMENT 34 0.0002
890 SWELLING FACE 16 0.0002
891 FEELING HOT 15 0.0002
892 INJECTION SITE WARMTH 5 0.0002
893 VISUAL ACUITY REDUCED 8 0.0002
894 LEUKOPENIA 12 0.0002
895 CHILLS 28 0.0002
896 HALLUCINATION 18 0.0002
897 CARDIOVASCULAR DISORDER 6 0.0002
898 PAIN IN EXTREMITY 69 0.0002
899 IRRITABLE BOWEL SYNDROME 5 0.0002
900 UNRESPONSIVE TO STIMULI 6 0.0002
901 DISEASE RECURRENCE 11 0.0002
902 MYALGIA 39 0.0002
903 TREMOR 38 0.0002
904 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
905 INTENTIONAL PRODUCT MISUSE 20 0.0002
906 HYPOAESTHESIA 34 0.0002
907 LIMB DISCOMFORT 7 0.0002
908 SKIN EXFOLIATION 19 0.0002
909 SWOLLEN TONGUE 7 0.0002
910 THROAT IRRITATION 10 0.0002
911 DYSPHONIA 13 0.0002
912 FREQUENT BOWEL MOVEMENTS 6 0.0002
913 RASH PRURITIC 12 0.0002
914 OVERDOSE 47 0.0002
915 HIP FRACTURE 7 0.0002
916 ABNORMAL DREAMS 6 0.0002
917 PROCEDURAL PAIN 6 0.0002
918 LACTIC ACIDOSIS 7 0.0002
919 WOUND 6 0.0002
920 LIP SWELLING 7 0.0002
921 HYPERHIDROSIS 27 0.0002
922 RECTAL HAEMORRHAGE 9 0.0002
923 HYPERSOMNIA 6 0.0002
924 ERYTHEMA 43 0.0002
925 GAIT DISTURBANCE 40 0.0002
926 TYPE 2 DIABETES MELLITUS 7 0.0002
927 NEUTROPENIA 28 0.0002
928 DYSSTASIA 6 0.0002
929 AGITATION 15 0.0002
930 DRUG INEFFECTIVE 266 0.0002
931 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
932 AMNESIA 13 0.0002
933 UNEVALUABLE EVENT 15 0.0002
934 DYSKINESIA 8 0.0002
935 NECK PAIN 11 0.0002
936 EMOTIONAL DISORDER 6 0.0002
937 DIPLOPIA 5 0.0002
938 MUCOSAL INFLAMMATION 5 0.0002
939 ARTHRALGIA 79 0.0002
940 PAIN 116 0.0002
941 EAR INFECTION 5 0.0002
942 ASTHMA 21 0.0002
943 HYPERSENSITIVITY 34 0.0002
944 EXPOSURE DURING PREGNANCY 11 0.0002
945 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
946 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
947 RASH ERYTHEMATOUS 8 0.0002
948 INFUSION RELATED REACTION 11 0.0002
949 ARTHRITIS 13 0.0002
950 ALOPECIA 32 0.0002
951 EYE PAIN 9 0.0002
952 COLITIS 6 0.0002
953 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
954 THERAPY NON-RESPONDER 7 0.0002
955 MOVEMENT DISORDER 5 0.0002
956 URTICARIA 26 0.0002
957 MOBILITY DECREASED 11 0.0002
958 ANXIETY 43 0.0002
959 EXPIRED PRODUCT ADMINISTERED 5 0.0002
960 BREAST CANCER 14 0.0002
961 COGNITIVE DISORDER 7 0.0001
962 GAIT INABILITY 5 0.0001
963 SUICIDE ATTEMPT 9 0.0001
964 VISION BLURRED 20 0.0001
965 ARTHROPATHY 8 0.0001
966 INJECTION SITE SWELLING 11 0.0001
967 INJURY 10 0.0001
968 NEUROPATHY PERIPHERAL 13 0.0001
969 INFLUENZA LIKE ILLNESS 11 0.0001
970 PARAESTHESIA 21 0.0001
971 DISTURBANCE IN ATTENTION 7 0.0001
972 INJECTION SITE ERYTHEMA 16 0.0001
973 BURNING SENSATION 9 0.0001
974 RENAL CANCER 6 0.0001
975 BLINDNESS 5 0.0001
976 VISUAL IMPAIRMENT 15 0.0001
977 PROSTATE CANCER 9 0.0001
978 IRRITABILITY 6 0.0001
979 SUICIDAL IDEATION 9 0.0001
980 ANAPHYLACTIC REACTION 5 0.0001
981 INJECTION SITE PAIN 25 0.0001
982 ACNE 6 0.0001
983 TOXICITY TO VARIOUS AGENTS 13 0.0001
984 INJECTION SITE HAEMORRHAGE 6 0.0001
985 INJECTION SITE PRURITUS 5 0.0001
986 TREATMENT FAILURE 6 0.0001
987 COMPLETED SUICIDE 6 0.0001
988 FLUSHING 7 0.0001
989 MUSCULOSKELETAL STIFFNESS 6 0.0001
990 RHEUMATOID ARTHRITIS 7 0.0001